RoosterBio and AGC Biologics Announce Collaboration to
New partnership delivers clinically proven products and manufacturing processes for advanced therapies...
Source: globenewswire.com
Page 6 - Master Files News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Master Files. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Master Files Today - Breaking & Trending Today
Amphastar Pharmaceuticals, Inc.: Amphastar Receives FDA Approval for Regadenoson
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 24, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New
Source: finanznachrichten.de
Amphastar Pharmaceuticals, Inc.: Amphastar Receives FDA Approval for Ganirelix Acetate Injection
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 8, 2022 / Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New
Source: finanznachrichten.de
How biosimilars are expanding options for patient care
Biosimilars are large, complex molecules with high similarity to an existing and licensed biotherapeutic product, developed for use when the current patent comes to an end. In recent years, biosimilars have led to more accessible treatment for a large variety of diseases due to more competitive pricing and greater accessibility for a large variety of diseases.
Source: selectscience.net
Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021
Reports Net Revenues of $120.9 Million for the Three Months Ended December 31, 2021RANCHO CUCAMONGA, CA / ACCESSWIRE / March 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the
Source: finanznachrichten.de